ES2063890T3 - Derivados y analogos de monoetilglicinaxilidina y su produccion y uso. - Google Patents

Derivados y analogos de monoetilglicinaxilidina y su produccion y uso.

Info

Publication number
ES2063890T3
ES2063890T3 ES90125063T ES90125063T ES2063890T3 ES 2063890 T3 ES2063890 T3 ES 2063890T3 ES 90125063 T ES90125063 T ES 90125063T ES 90125063 T ES90125063 T ES 90125063T ES 2063890 T3 ES2063890 T3 ES 2063890T3
Authority
ES
Spain
Prior art keywords
analogue
monoetilglicinaxilidina
analogs
derivatives
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90125063T
Other languages
English (en)
Inventor
Lawrence Kolaczkowski
Mark Littlefield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2063890T3 publication Critical patent/ES2063890T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B11/00—Diaryl- or thriarylmethane dyes
    • C09B11/04—Diaryl- or thriarylmethane dyes derived from triarylmethanes, i.e. central C-atom is substituted by amino, cyano, alkyl
    • C09B11/06—Hydroxy derivatives of triarylmethanes in which at least one OH group is bound to an aryl nucleus and their ethers or esters
    • C09B11/08—Phthaleins; Phenolphthaleins; Fluorescein
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B29/00—Monoazo dyes prepared by diazotising and coupling
    • C09B29/10—Monoazo dyes prepared by diazotising and coupling from coupling components containing hydroxy as the only directing group
    • C09B29/12—Monoazo dyes prepared by diazotising and coupling from coupling components containing hydroxy as the only directing group of the benzene series
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

SE REVELA UN SUSTITUTO DE LA MONOETILGLICINAXILIDIDA O SUSTANCIA ANALOGA. LA XILIDIDA O LA SUSTANCIA ANALOGA TIENE LA ESTRUCTURA DE LA FIGURA 1 DE LOS DIBUJOS ADJUNTOS DONDE M ES CH SUB 2 NHCH SUB 2 CH SUB 3, CH SUB 2 CH SUB 2 CH SUB 2 CH SUB 3 O CH SUB 2 OCH SUB 2 CH SUB 3, UNA DE LAS "Y" ES H Y LA OTRA ES UNA PROTEINA O FLUOROSCEINA A PARTES IGUALES, QUIMICAMENTE UNIDAS A LA GLICINEXILIDIDA O LA SUSTANCIA ANALOGA IGUALMENTE A PARTES IGUALES. TAMBIEN SE REVELA UN METODO PARA LLEVAR A CABO INMUNOENSAYOS PARA MEGX, QUE TIENE LA ESTRUCTURA DE LA FIGURA 3 DE LOS DIBUJOS ADJUNTOS. EL METODO PARA LLEVAR A CABO LOS INMUNOENSAYOS IMPLICA EL USO DE LOS COMPUESTOS ANTERIORES COMO MARCADORES RADIOACTIVOS E INMUNOGENOS.
ES90125063T 1989-12-22 1990-12-21 Derivados y analogos de monoetilglicinaxilidina y su produccion y uso. Expired - Lifetime ES2063890T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/455,467 US5099000A (en) 1989-12-22 1989-12-22 Derivatives and analogues of monoethylglycinexylidide and their production and use

Publications (1)

Publication Number Publication Date
ES2063890T3 true ES2063890T3 (es) 1995-01-16

Family

ID=23808924

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90125063T Expired - Lifetime ES2063890T3 (es) 1989-12-22 1990-12-21 Derivados y analogos de monoetilglicinaxilidina y su produccion y uso.

Country Status (8)

Country Link
US (2) US5099000A (es)
EP (1) EP0437800B1 (es)
JP (1) JPH04120058A (es)
AT (1) ATE111489T1 (es)
AU (1) AU639287B2 (es)
CA (1) CA2032228A1 (es)
DE (1) DE69012541T2 (es)
ES (1) ES2063890T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5099000A (en) * 1989-12-22 1992-03-24 Abbott Laboratories Derivatives and analogues of monoethylglycinexylidide and their production and use
US6489119B1 (en) * 1996-03-29 2002-12-03 Elan Pharmaceuticals, Inc. Analgesic screening method and composition
KR101014438B1 (ko) * 2008-09-26 2011-02-14 동아제약주식회사 탁산 유도체의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058511A (en) * 1976-01-12 1977-11-15 Syva Company Tegretol antigens and antibodies
US4069105A (en) * 1977-03-03 1978-01-17 Syva Company Lidocaine antigens and antibodies
US4593089A (en) * 1980-07-30 1986-06-03 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluorescein aminoglycosides
US4668640A (en) * 1981-12-11 1987-05-26 Abbott Laboratories Fluorescence polarization immunoassay utilizing substituted carboxyfluoresceins
US4510251A (en) * 1982-11-08 1985-04-09 Abbott Laboratories Fluorescent polarization assay for ligands using aminomethylfluorescein derivatives as tracers
US4614823A (en) * 1982-11-08 1986-09-30 Abbott Laboratories Aminomethylfluorescein derivatives
US4650771A (en) * 1983-11-04 1987-03-17 Miles Laboratories, Inc. Immunogens, antibodies, labeled conjugates, and related derivatives for lidocaine and analogs thereof
EP0252404A2 (en) * 1986-07-09 1988-01-13 Abbott Laboratories 5-Hydroxy-3-indoleacetic acid fluorescence polarization immunoassay
US5099000A (en) * 1989-12-22 1992-03-24 Abbott Laboratories Derivatives and analogues of monoethylglycinexylidide and their production and use

Also Published As

Publication number Publication date
US5099000A (en) 1992-03-24
JPH04120058A (ja) 1992-04-21
EP0437800A1 (en) 1991-07-24
CA2032228A1 (en) 1991-06-23
ATE111489T1 (de) 1994-09-15
DE69012541D1 (de) 1994-10-20
DE69012541T2 (de) 1995-03-23
EP0437800B1 (en) 1994-09-14
AU6839790A (en) 1991-06-27
AU639287B2 (en) 1993-07-22
US5319105A (en) 1994-06-07

Similar Documents

Publication Publication Date Title
IT7928377A0 (it) Procedimento per la produzione dicombustibile ottenuto dall'essicamento per polverizzazione di fanghi.
FI910034A0 (fi) 3-aminopiperidinderivat och liknande kvaeve innehaollande heterocykler.
ES516254A0 (es) "un metodo de producir derivados de 1-sulfo-2-oxoazetidina".
ES509900A0 (es) "un metodo de preparacion de derivados de imidazolidinonas".
ATE98630T1 (de) Radiohalogenierte verbindungen fuer markierung von spezifischen stellen.
DE69331721T2 (de) Neue carbamazepin hapten Analoge
NO892459D0 (no) Innretning for omdannelse av ytre unyttige oscillerende bevegelser til nyttig dreiemoment.
NO903138L (no) Fremgangsmaate for konservering av planteembryoer.
IT8420358A0 (it) Procedimento di preparazione di derivati 1-carbamoilmetilici di 4-idrossi-2-osso-pirrolidina nonche' di intermedi per ottenere tali composti.
ES2063890T3 (es) Derivados y analogos de monoetilglicinaxilidina y su produccion y uso.
IT7950309A0 (it) Composti furanici sostituiti dotati di proprieta' farmacologiche
IT1162795B (it) Procedimento per la rimozione di composti organici dal ciclo di produzione di terra d'alluminio
FI892681A (fi) Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel.
ES511985A0 (es) "un metodo de preparar derivados de pirazolina".
MC1918A1 (fr) Derives de l'imidazodiazepine
FI890517A0 (fi) Foerfarande och anordning foer befuktning av partiklar i gasstroemningen.
ES531223A0 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina
ATE76300T1 (de) Verfahren zur abtrennung und reinigung von t-pa.
ES514045A0 (es) "un metodo de preparar derivados de oxotienobenzoxepina".
JPS5424888A (en) Novel 7alpha-methoxycephalosporins and their preparation
IT1192784B (it) Procedimento per la preparazione della n ciano n metil (2 mercaptoetil) guanidina
FI892911A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen (+)-1-/(3,4,5-trimetoksi)bentsyylioksimetyyli/-1-fenyyli-N,N-dimetyyli-n-propyyliamiinin valmistamiseksi
ES510626A0 (es) "un metodo de producir derivados de cefalosporina".
IT1229214B (it) Processo per la sintesi della n metil 3,4 dimetossifeniletilamina
FI873000A0 (fi) Substituoituja 1,2,3-tiadiatsoli-4-tiolaatteja

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 437800

Country of ref document: ES